Back to Search Start Over

Managing Q Fever during Pregnancy The Benefits of Long-Term Cotrimoxazole Therapy.

Authors :
Carcopino, Xavier
Raoult, Didier
Bretelle, Florence
Boubli, Leon
Stein, Andreas
Source :
Clinical Infectious Diseases. 9/1/2007, Vol. 45 Issue 5, p548-555. 8p. 5 Charts.
Publication Year :
2007

Abstract

Background. Q fever is a zoonosis caused by Coxiella burnetii. During pregnancy, it may result in obstetric complications, such as spontaneous abortion, intrauterine growth retardation, intrauterine fetal death, and pre-mature delivery. Pregnant women are exposed to the risk of chronic Q fever. Methods. We included 53 pregnant women who received a diagnosis of Q fever. We compared the incidence of obstetric and maternal Q fever complications for women who received long-term cotrimoxazole treatment (n = 16) with that for women who did not receive long-term cotrimoxazole treatment (n = 37); long-term cotrimoxazole treatment was defined as oral administration of trimethoprim-sulfamethoxazole during at least 5 weeks of pregnancy. Results. Obstetric complications were observed in 81.1% of pregnant women who did not receive long-term cotrimoxazole therapy: 5 (13.5%) women experienced spontaneous abortions, 10 (27%) experienced intrauterine growth retardation, 10 (27%) experienced intrauterine fetal death, and 10 (27%) experienced premature delivery. Oligoamnios was observed in 4 patients (10.8%). Obstetric complications were found to occur significantly more often in patients infected during their first trimester of pregnancy than in those infected later (P = .032). The outcome of the pregnancy was found to depend on placental infection by C. burnetii (P = .013). Long-term cotrimoxazole treatment protected against maternal chronic Q fever (P = .001), placental infection (P = .038), and obstetric complications (P = .009), especially intrauterine fetal death (P .018), which was found to be related to placental infection (P = .008). Conclusions. Q fever during pregnancy results in severe obstetric complications, including oligoamnios. Because of its ability to protect against placental infection, intrauterine fetal death, and maternal chronic Q fever, long- term cotrimoxazole treatment should be used to treat pregnant women with Q fever. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10584838
Volume :
45
Issue :
5
Database :
Academic Search Index
Journal :
Clinical Infectious Diseases
Publication Type :
Academic Journal
Accession number :
26646517
Full Text :
https://doi.org/10.1086/520661